GRPR and neoplasm: In total, 205 tumour samples were characterized as having low/none or moderate/high expression of the GRPR, and these were correlated with clinical characteristics and survival outcomes.<h4>Results</h4>In total, 80% of the tumour samples exhibited moderate or high expression of GRPR.